This is why Merck is buying Cidara Therapeutics for $9.2 billion, and why Wall Street is happy

1 week ago 7
ARTICLE AD BOX
Merck is facing a patent cliff for Keytruda and upheaval in the market for Gardasil.
Read Entire Article
  1. Homepage
  2. Finance
  3. This is why Merck is buying Cidara Therapeutics for $9.2 billion, and why Wall Street is happy

Related

Nvidia’s stock drops on Google fears. Are investors missing the point?

Nvidia’s stock drops on Google fears. Are investors missing ...

41 minutes ago 0
A ‘tale of two retirements’ shows only the rich are saving more — while most Americans are putting away much less

A ‘tale of two retirements’ shows only the rich are saving m...

1 hour ago 0
Home sellers face a tough choice right now: cut their asking price, or roll the dice on a better deal later

Home sellers face a tough choice right now: cut their asking...

1 hour ago 0

Trending

Popular

Can Pidcock win big & why did it end at Ineos?

Can Pidcock win big & why did it end at Ineos?

8 months ago 385
Netflix scuttles plans to add six previously announced games to its service

Netflix scuttles plans to add six previously announced games...

9 months ago 343
‘I didn’t want to spend time with my children. I was just going through the motions’: the pain of parental burnout

‘I didn’t want to spend time with my children. I was just go...

9 months ago 337
‘Slanted’ Review: Extreme Makeover Satire Critiques Lopsided Beauty Standards Through Asian Eyes

‘Slanted’ Review: Extreme Makeover Satire Critiques Lopsided...

8 months ago 316
OpenAI co-founder John Schulman has left Anthropic after less than a year

OpenAI co-founder John Schulman has left Anthropic after les...

9 months ago 306
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Nexa News 2025. All rights are reserved